Enhanced tissue production through redox control in stem cell-laden hydrogels

Tissue Engineering - Part A

Volumn 19, Issue 17-18, 2013, Pages 2014-2023

  Reid, Branden ^a,b   Afzal, Junaid M ^c   Mccartney, Annemarie M ^a   Abraham, M Roselle ^c   O'Rourke, Brian ^c   Elisseeff, Jennifer H ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Johns Hopkins University   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; BIOCHEMISTRY; CELL PROLIFERATION; HYDROGELS; MAGNESIUM PRINTING PLATES; MONOLAYERS; PAPERMAKING MACHINERY; PATHOLOGY; PEPTIDES; POLYETHYLENE GLYCOLS; STEM CELLS; TISSUE;

ADIPOGENIC DIFFERENTIATIONS; ADIPOSE DERIVED STEM CELLS; BIOMATERIAL SCAFFOLDS; METABOLIC CHARACTERISTICS; MITOCHONDRIAL MEMBRANE POTENTIAL; OSTEOGENIC DIFFERENTIATION; REACTIVE OXYGEN SPECIES; THERAPEUTIC MOLECULES;

SCAFFOLDS (BIOLOGY);

ANTIOXIDANT; CARNITINE; MACROGOL; REACTIVE OXYGEN METABOLITE; TISSUE SCAFFOLD; HYDROGEL; MACROGOL DERIVATIVE;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ARTICLE; BIOENERGY; BONE DEVELOPMENT; CELL ADHESION; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN ADIPOSE DERIVED STEM CELL; HUMAN CELL; HYDROGEL; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; TISSUE ENGINEERING; ADIPOSE TISSUE; CELL CULTURE; CHEMISTRY; CYTOLOGY; OXIDATION REDUCTION REACTION; PHYSIOLOGY; PROCEDURES; STEM CELL; METHODOLOGY;

PHOS;

ADIPOGENESIS; ADIPOSE TISSUE; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; HYDROGELS; OSTEOGENESIS; OXIDATION-REDUCTION; POLYETHYLENE GLYCOLS; STEM CELLS; TISSUE ENGINEERING;

EID: 84881134839     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0515     Document Type: Article

References (58)

1. Griffith, L.G., and Naughton, G. Tissue engineering - current challenges and expanding opportunities. Science 295, 1009, 2002
2. Atala, A. Engineering tissues, organs and cells. J Tissue Eng Regen Med 1, 83, 2007
3. Cairns, R.A., Harris, I.S., and Mak, T.W. Regulation of cancer cell metabolism. Nat Rev Cancer 11, 85, 2011
4. Vander Heiden, M.G., Cantley, L.C., and Thompson, C.B. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324, 1029, 2009
5. Chen, C.-T., Hsu, S.-H., and Wei, Y.-H. Mitochondrial bioenergetic function and metabolic plasticity in stem cell differentiation and cellular reprogramming. Biochim Biophys Acta 1820, 571, 2012
6. Shyh-Chang, N., Zheng, Y., Locasale, J.W., and Cantley, L.C. Human pluripotent stem cells decouple respiration from energy production. EMBO J 30, 4851, 2011
7. Funes, J.M., Quintero, M., Henderson, S., Martinez, D., Qureshi, U., Westwood, C., et al. Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc Natl Acad Sci U S A 104, 6223, 2007
8. Chung, S., Dzeja, P.P., Faustino, R.S., Perez-Terzic, C., Behfar, A., and Terzic, A. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat Clin Pract Cardiovasc Med 4 Suppl 1, S60, 2007
9. Varum, S., Rodrigues, A.S., Moura, M.B., Momcilovic, O., Easley, C.A.T., Ramalho-Santos, J., et al. Energy metabolism in human pluripotent stem cells and their differentiated counterparts. PLoS One 6, e20914. 2011
10. Chen, Q., Vazquez, E.J., Moghaddas, S., Hoppel, C.L., and Lesnefsky, E.J. Production of reactive oxygen species by mitochondria. J Biol Chem 278, 36027, 2003
11. D'Autreaux, B., and Toledano, M.B. ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8, 813, 2007
12. Tormos Kathryn, V., Anso, E., Hamanaka Robert, B., Eisenbart, J., Joseph, J., Kalyanaraman, B., et al. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab 14, 537, 2011
13. Chen, C.-T, Shih, Y.-R.V., Kuo, T.K., Lee, O.K., and Wei, Y.- H. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells 26, 960, 2008
14. Imhoff, B., and Hansen, J. Differential redox potential profiles during adipogenesis and osteogenesis. Cell Mol Biol Lett 16, 149, 2011
15. Lutolf, M.P., Lauer-Fields, J.L., Schmoekel, H.G., Metters, A.T., Weber, F.E., Fields, G.B., et al. Synthetic matrix metalloproteinase- sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics. Proc Natl Acad Sci 100, 5413, 2003
16. Nguyen, K.T., and West, J.L. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 23, 4307, 2002
17. Lin, C.-C., and Anseth, K. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res 26, 631, 2009
18. Hern, D.L., and Hubbell, J.A. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res 39, 266, 1998
19. Maheshwari, G., Brown, G., Lauffenburger, D.A., Wells, A., and Griffith, L.G. Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci 113, 1677, 2000
20. Hsiong, S.X., B.T., Huebsch, N., and Mooney, D.J. Cyclic arginine-glycine-aspartate peptides enhance three-dimensional stem cell osteogenic differentiation. Tissue Eng Part A 15, 263, 2009
21. Salinas, C.N., and Anseth, K.S. The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability. J Tissue Eng Regen Med 2, 296, 2008
22. Mitchell, J.B., McIntosh, K., Zvonic, S., Garrett, S., Floyd, Z.E., Kloster, A., et al. Immunophenotype of human adiposederived cells: Temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24, 376, 2006
23. Williams, C.G., Kim, T.K., Taboas, A., Malik, A., Manson, P., and Elisseeff, J. In vitro chondrogenesis of bone marrowderived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng 9, 679, 2004
24. Nicholls, D.G., and Ferguson, S.J. Bioenergetics 3. Boston: Academic Press, 2002
25. Calo, L.A., Pagnin, E., Davis, P.A., Semplicini, A., Nicolai, R., Calvani, M., et al. Antioxidant effect of l-carnitine and its short chain esters: Relevance for the protection fromoxidative stress related cardiovascular damage. Int J Cardiol 107, 54, 2006
26. Lee, K., Silva, E.A., and Mooney, D.J. Growth factor delivery- based tissue engineering: General approaches and a review of recent developments. J R Soc Interface 8, 153, 2011
27. Stoppel, W.L., and Roberts, S.C. Oxygen supply for tissue engineering. In: Bhatia, S.K. (Ed.) Engineering Biomaterials for Regenerative Medicine. New York: Springer, 2012, pp. 41-86
28. Gimble, J., and Guilak, F. Adipose-derived adult stem cells: Isolation, characterization, and differentiation potential. Cytotherapy 5, 362, 2003
29. Gimble, J.M., Katz, A.J., and Bunnell, B.A. Adipose-derived stem cells for regenerative medicine. Circ Res 100, 1249, 2007
30. Meza-Zepeda, L.A., Noer, A., Dahl, J.A., Micci, F., Myklebost, O., and Collas, P. High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. J Cell Mol Med 12, 553, 2008
31. Dahl, J.A., Duggal, S., Coulston, N., Millar, D., Melki, J., Shahdadfar, A., et al. Genetic and epigenetic instability of human bone marrowmesenchymal stemcells expanded in autologous serum or fetal bovine serum. Int J Dev Biol 52, 1033, 2008
32. Fang, B., Song, Y., Liao, L., Zhang, Y., and Zhao, R.C. Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versushost disease. Transplant Proc 39, 3358, 2007
33. Garcia-Olmo, D., Garcia-Arranz, M., and Herreros, D. Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease. Expert Opin Biol Ther 8, 1417, 2008
34. Gulcin, I. Antioxidant and antiradical activities of L-carnitine. Life Sci 78, 803, 2006
35. Murphy Michael, P., Holmgren, A., Larsson, N.-G., Halliwell, B., Chang Christopher, J., Kalyanaraman, B., et al. Unraveling the biological roles of reactive oxygen species. Cell Metab 13, 361, 2011
36. Silva, E.A., Kim, E.S., Kong, H.J., and Mooney, D.J. Materialbased deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A 105, 14347, 2008
37. Passier, R., van Laake, L.W., and Mummery, C.L. Stem-cellbased therapy and lessons from the heart. Nature 453, 322, 2008
38. Tibbitt, M.W., and Anseth, K.S. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng 103, 655, 2009
39. Willerth, S.M., and Sakiyama-Elbert, S.E. Combining Stem Cells and Biomaterial Scaffolds for Constructing Tissues and Cell Delivery. Cambridge, MA: StemBook, 2008
40. Gilmore, A.P. Anoikis. Cell Death Differ 12 Suppl 2, 1473, 2005
41. Nuttelman, C.R., Tripodi, M.C., and Anseth, K.S. Synthetic hydrogel niches that promote hMSC viability. Matrix Biol 24, 208, 2005
42. Benoit, D.S., Tripodi, M.C., Blanchette, J.O., Langer, S.J., Leinwand, L.A., and Anseth, K.S. Integrin-linked kinase production prevents anoikis in human mesenchymal stem cells. J Biomed Mater Res Part A 81, 259, 2007
43. Gottlieb, E., Armour, S.M., Harris, M.H., and Thompson, C.B. Mitochondrial membrane potential regulates matrix configuration and cytochrome c release during apoptosis. Cell Death Differ 10, 709, 2003
44. Guo, Y., Srinivasula, S.M., Druilhe, A., Fernandes-Alnemri, T., and Alnemri, E.S. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 277, 13430, 2002
45. Kroemer, G., and Reed, J.C. Mitochondrial control of cell death. Nat Med 6, 513, 2000
46. Winterbourn, C.C. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol 4, 278, 2008
47. Rungtabnapa, P., Nimmannit, U., Halim, H., Rojanasakul, Y., and Chanvorachote, P. Hydrogen peroxide inhibits nonsmall cell lung cancer cell anoikis through the inhibition of caveolin-1 degradation. Am J Physiol Cell Physiol 300, C235, 2011
48. Halim, H., and Chanvorachote, P. Long-term hydrogen peroxide exposure potentiates anoikis resistance and anchorage- independent growth in lung carcinoma cells. Cell Biol Int 36, 1055, 2012
49. Lee, K.Y., Alsberg, E., Hsiong, S., Comisar, W., Linderman, J., Ziff, R., et al. Nanoscale Adhesion Ligand Organization Regulates Osteoblast Proliferation and Differentiation. Nano Lett 4, 1501, 2004
50. Kloxin, A.M., Kasko, A.M., Salinas, C.N., and Anseth, K.S. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 324, 59, 2009
51. Yang, F., Williams, C.G., Wang, D.A., Lee, H., Manson, P.N., and Elisseeff, J. The effect of incorporating RGD adhesive peptide in polyethylene glycol diacrylate hydrogel on osteogenesis of bone marrow stromal cells. Biomaterials 26, 5991, 2005
52. Connelly, J.T., Garcia, A.J., and Levenston, M.E. Interactions between integrin ligand density and cytoskeletal integrity regulate BMSC chondrogenesis. J Cell Physiol 217, 145, 2008
53. Kim, K.S., Choi, H.W., Yoon, H.E., and Kim, I.Y. Reactive oxygen species generated by NADPH oxidase 2 and 4 are required for chondrogenic differentiation. J Biol Chem 285, 40294, 2010
54. Huebsch, N., Arany, P.R., Mao, A.S., Shvartsman, D., Ali, O.A., Bencherif, S.A., et al. Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate. Nat Mater 9, 518, 2010
55. Murphy, M.P. How mitochondria produce reactive oxygen species. Biochem J 417, 1, 2009
56. Brand, K.A., and Hermfisse, U. Aerobic glycolysis by proliferating cells: A protective strategy against reactive oxygen species. FASEB J 11, 388, 1997
57. Gatenby, R.A., and Gillies, R.J. Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4, 891, 2004.
58. Mates, J.M., Segura, J.A., Alonso, F.J., and Marquez, J. Intracellular redox status and oxidative stress: Implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol 82, 273, 2008.